Thus, the conjugate of {HEAD ~ the present invention} has one or more improved properties as compared to commercially available rFVIIa, including increased functional in vivo half life and increased plasma half life, and increased bioavailability and reduced sensitivity to {TAIL ~ proteolytic degradation} 
Thus , the conjugate of { HEAD ~ the present invention } has one or more improved properties as compared to commercially available rFVIIa , including increased functional in vivo half life and increased plasma half life , and increased bioavailability and reduced sensitivity to { TAIL ~ proteolytic degradation }
OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL